US › Healthcare

Ascentage Pharma Group International (AAPG)

US · Healthcare · Biotechnology

$16.69-0.68%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$334.1M

Revenue YoY

+113.0%

Net profit

$-640.0M

Profit YoY

-12.6%

EPS

$0.00

EPS estimate

$0.00

Net margin

-191.5%

Key statistics

Market cap

$1.63B

Forward P/E

0.0

P/B

8.31

Book value

$2.12

EPS (TTM)

$-2.06

52-week high

$48.45

52-week low

$16.36

50-day MA

$18.48

200-day MA

$24.88

Beta

0.66

Analyst view

Analysts rate Ascentage Pharma Group International a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $47.56.

Shareholding

Institutions

0.05%

Largest institutional holders

Fund	Stake
Point72 Asset Management, L.P.	0.02%
XY Capital Ltd	0.01%
Tower Research Capital LLC	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
UBS Group AG	0.00%
EverSource Wealth Advisors, LLC	0.00%
Royal Bank of Canada	0.00%
Bell Investment Advisors, Inc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Ascentage Pharma Group International — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.